Recursion to Participate in Upcoming Investor Conference
02 avr. 2024 08h00 HE
|
Recursion Pharmaceuticals
SALT LAKE CITY, April 02, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its...
Recursion Publishes Annual Environmental, Social and Governance Report
26 mars 2024 08h00 HE
|
Recursion Pharmaceuticals
SALT LAKE CITY, March 26, 2024 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery, today announced...
Recursion Hosts Second Annual Rare Disease Day Events for Utah’s Rare Disease Community
01 mars 2024 14h58 HE
|
Recursion Pharmaceuticals
SALT LAKE CITY, March 01, 2024 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, hosted its second annual Rare...
Recursion to Participate in Upcoming Investor Conferences
01 mars 2024 07h59 HE
|
Recursion Pharmaceuticals
SALT LAKE CITY, March 01, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its...
Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2023 Financial Results
27 févr. 2024 16h05 HE
|
Recursion Pharmaceuticals
Multiple clinical programs from Recursion’s first generation platform are on track to read out Phase 2 data in H2 2024 and H1 2025 with additional second generation programs approaching IND in the...
Recursion to Host Public L(earnings) Call on February 27
20 févr. 2024 07h59 HE
|
Recursion Pharmaceuticals
SALT LAKE CITY, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, announced today it will provide...
Altitude Lab Startups Raise Over $120M in Capital
24 janv. 2024 09h00 HE
|
Recursion Pharmaceuticals
SALT LAKE CITY, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Altitude Lab today announced that its incubating startups raised over $120M in early-stage funding since commencing operations in 2020. Altitude Lab...
Recursion Unveils LOWE Drug Discovery Software at the J.P. Morgan Healthcare Conference
08 janv. 2024 10h59 HE
|
Recursion Pharmaceuticals
SAN FRANCISCO, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today presented a demonstration...
Recursion to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 8
03 janv. 2024 08h00 HE
|
Recursion Pharmaceuticals
SALT LAKE CITY, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced that Chris...
Recursion and Enamine to Generate and Design Enriched Compound Libraries for Global Drug Discovery Industry
20 déc. 2023 07h59 HE
|
Recursion Pharmaceuticals
KYIV, Ukraine and SALT LAKE CITY, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today...